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Summary 
The primary tumors that typically cause carcinomatous meningitis include lung cancer, breast cancer, 
leukemia, lymphoma and melanoma. A variety of neurological signs and symptoms can be seen depending 
on the extent and location of the meningeal metastasis. Once the diagnosis of carcinomatous meningitis is 
confirmed, the search for the primary tumor can be a challenge and at times may require extensive 
radiographic or even surgical evaluation to obtain specimen for pathological confirmation. Here we report 
a patient who presented with bilateral cranial nerve VIII and cerebellar symptoms, and was diagnosed with 
carcinomatous meningitis. Only after an exploratory laporatomy did it become clear that the initial 
symptoms were related to a metastatic gallbladder carcinoma. 
Introduction 
Although numerous primary cancers have been 
reported to cause carcinomatous meningitis, pri-
mary gallbladder carcinoma rarely metastasizes to 
the meninges. There are only five such reported 
cases in the English literature [1-5]. Here we report 
a woman who presented with cranial nerve VIII 
symptoms and ataxia and was found to have car-
cinomatous meningitis. An extensive search for the 
primary tumor ultimately led to the diagnosis of 
gallbladder carcinoma. 
Case report 
A 51 year old woman with history of alcoholism 
and hypothyroidism was referred to ENT clinic for 
evaluation of I-month history of progressive right 
ear tinnitus and hearing loss, vertigo, and ataxia 
without headache or weight loss. Neurological 
examination revealed hypometric saccades and 
impaired hearing in both ears, right worse than the 
left. The patient had a wide-based ataxic gait. On a 
high-resolution MRI of the internal auditory ca-
nals, bilateral enhancement of cranial nerve VIII 
and cerebellar folia was noted, suggestive of an 
inflammatory process such as meningitis. 
Initial blood chemistry and metabolic screens 
were normal other than a macrocytic anemia and 
elevated liver function enzymes. Cerebral spinal 
fluid (CSF) showed 28 mg/dl glucose (serum glu-
cose 101 mg/dl), 166 mg/dl protein, 0 red blood 
cells, and 145/111 white blood cells with 74% lym-
phocytes. The opening pressure during the lumbar 
puncture was 15 cm H20. CSF cytology revealed 
malignant cells with characteristic signet ring 
morphology that were cytokeratin and carcino-
embryonic antigen (CEA) positive, consistent with 
metastatic adenocarcinoma (Figure 1). A repeat 
MRI 1 week later showed progressive enhance-
ment along the ventral surface of the brainstem. 
cranial nerves II, V, VII and VIII, as well as many 
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Figure J. Cerebrospinal fluid. Cytospin of the patient's cere-
brospinal fluid (papanicolau stain) shows single cells and 
clusters of malignant cells having signet ring morphology. 
cerebral sulci and the right sylvian fissure (Fig-
ure 2). 
An extensive work-up to identify a primary 
malignancy ensued. The serum CEA was elevated 
at 12.7 ng/ml (normal range 0.0--3.0). Serum tumor 
markers were negative for bladder tumor associ-
Figure 2. El'lhancing cranial nerves. Postcontrast-enhanced 
coronal MRI of the Brain demonstrating enhancing bilateral 
cranial nerve VIII and cerebellar folia. 
ated antigen, alpha-fetoprotein (AFP), CA (cancer 
antigen) 15--3, CA 27.29 (breast cancer), CA 19-9 
(pancreatic cancer) and CA 125 (ovarian cancer). 
Mammogram and pap smear were unremarkable. 
Computed Tomography (CT) of chest was normal. 
Abdominal and pelvic CT demonstrated complex 
appearing cystic masses in the ovaries and a gall-
bladder with abundant gallstones and sludge. 
There were no enhancing lesions in the liver. Be-
cause of the abnormal appearing ovary and gall-
bladder on the CT scan, positive serum and CSF 
markers for CEA, and positive cytokeratin immu-
nohistochemical stain on the malignant cells in 
CSF, ovarian or GI tract cancer was suspected as 
the primary source. In order to obtain pathological 
specimen for definite diagnosis and possibly resec-
tion of the tumor, the patient underwent an 
exploratory laparotomy. She had a total abdomi-
nal hysterectomy, bilateral salpingo-oophorec-
tomy, cholecystectomy after intraoperative biopsy 
proved adenocarcinoma, and portal lymph node 
excision. During the operation, the gallbladder was 
found to be slightly enlarged, irregular in shape and 
firm to palpation. Microscopic examination of the 
ovaries showed cystic corpus luteum and follicl~s 
but no neoplastic changes. Pathological examina-
tion of the gallbladder demonstrated cholelithiasis 
and chronic cholecystitis with diffuse intestinal 
metaplasia and poorly differentiated signet ring cell 
adenocarcinoma localized to the gallbladder fun-
dus. The carcinoma extended through the full 
thickness of the wall and out to the external cau-
terized margin of the gallbladder fundus. The 
morphology of the signet ring cells was similar to 
that seen in the CSF (Figure 3). Interestingly, the 
portal lymph nodes were negative for metastases. 
Eight days after the laporatomy, an Ommaya 
reservoir was placed and the first dose of intra-
thecal thiotepa was given. The second dose was 
given 6 days later. Two days later the patient 
developed decreased oral intake, intractable vom-
iting, worsened ataxia, and became progressively 
obtunded. Empiric intravenous antibiotics were 
started for possible bacterial meningitis but re-
peated CSF analysis did not show evidence of 
infection. Repeat MRI of the brain showed more 
extensive leptomeningeal enhancement consistent 
with progression of carcinomatous meningitis. She 
subsequently developed respiratory distress and 
required intubation 7 days after the second dose of 
intrathecal chemotherapy. She was treated with 
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Figure 3. Gallbladder histology. Hematoxylin and eosin 
stained section of the gallbladder showing a poorly differenti-
ated invasive adenocarcinoma, which focally exhibits signet 
ring morphology. 
one dose of whole brain radiation therapy on the 
second day after being intubated. On the same day 
she developed EKG abnormalities and elevated 
cardiac enzymes indicating acute cardiac injury. 
CT angiogram and duplex ultrasound did not re-
veal any evidence of pulmonary embolism or deep 
venous thrombosis, respectively. On the following 
day she developed asystole and was not resusci-
tated. At autopsy, there was tumor infiltration in 
cranial nerves II, V, VII, VIII, and X, and the 
cerebral hemispheres, in addition to dorsal and 
ventral roots of the spinal cord (Figures 4-6). 
There was no evidence of hydrocephalus or sig-
nificant coronary atherosclerosis. We presumed her 
terminal cardiac events were related to metastatic 
involvement of the brainstem autonomic centers. 
Interestingly, the metastatic tumor was not found 
Figure 4. Brain gross pathology. Clouding and thickening of 
the meninges on the ventral surface of the brainstem. 
~,' l· 
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Figure 5. Meningeal histology. Hematoxylin and eosin stained 
section of the meninges reveals a subarachnoid infiltrate of 
poorly differentiated malignant cells, many of which exhibit 
signet ring morphology. 
Figure 6. Cranial nerve histology. Hematoxylin and eosin 
stained section of cranial nerve V illustrating infiltration of 
nerve by poorly differentiated malignant cells with signet ring 
morphology. 
outside of the nervous system. In summary, the 
disease progression in her case was rapid and re-
sulted in her death one month after the initial 
neurologic presentation. 
Discussion 
The incidence of carcinomatous meningitis has in-
creased in the past few decades. This increase has 
been attributed to the prolonged survival of cancer 
patients as a result of the advances in anti-cancer 
treatment, as well as heightened index of clinical 
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suspicion [6]. In one autopsy study, 8% of patients 
with systemic cancer were found to have tumor cell 
metastases in their meninges [7]. In those with lep-
tomeningeal metastases, 24% had concomitant 
parenchymal brain metastases [8]. The most likely 
solid tumors found to spread to the leptomeninges 
include lung cancer, breast cancer and melanoma. 
Other primary tumors that less commonly spread 
to leptomeninges include ovarian cancer [9], cervi-
cal cancer [10], renal cell carcinoma [11] and gastric 
adenocarcinoma [12J. Gallbladder carcinoma 
involving the leptomeninges has only been reported 
in very few instances. The symptoms of carcino-
matous meningitis are not specific to the primary 
cancer type. Our patient presented with hearing 
loss, tinnitus, vertigo and ataxia. Meningeal irrita-
tion from tumor infiltration can produce headache, 
nausea, vomiting and altered mentation. Visual loss 
and diplopia can be due to either direct cranial 
nerve damage or papilledema from hydrocephalus. 
Spinal cord leptomeningeal involvement can result 
in radicular pain, weakness and paresthesia, and 
bowel and bladder dysfunction. 
Definitive diagnosis requires identification of 
malignant cells in the CSF. The diagnosis can be 
supported by findings on CT with contrast or MRI 
with gadolinium and occasionally meningeal 
biopsy. The sensitivity of cytological diagnosis with 
one CSF examination is 54% but increases to 91 % 
with two-examinations [8J. Therefore, multiple 
lumbar punctures may be required to achieve a 
definitive diagnosis. Other CSF abnormalities 
associated with carcinomatous meningitis include 
low glucose, high protein, and lymphocytic pleo-
cytosis. CSF markers can be helpful in supporting 
the diagnosis of carcinomatosis. These include {J-
glucuronidase, CEA (carcinoembryonic antigen), 
{J-microglobulin, cancer specific monoclonal anti-
bodies, lactate dehydrogenase, and others [13J. 
These markers may prove helpful to increase the 
diagnostic yield in those patients with multiple taps 
with negative cytology or help to delineate the ori-
gin of the primary tumor, as this case illustrates. 
CSF cytology and neuroimaging are comple-
mentary in the diagnosis of carcinomatous men-
ingitis. Gadolinium-enhanced MRI of brain is 
considered more sensitive than contrast-enhanced 
CT in demonstrating the abnormalities caused by 
leptomeningeal metastasis [14J. The classic radio-
graphic findings on MRI for carcinomatous men-
ingitis include leptomeningeal enhancement, either 
in the brain (extending into the sulci of the cerebral 
hemispheres or the folia of the cerebellum), spinal 
cord, caudal equina, or subependymal areas. 
Enhancement of cranial nerves is highly suggestive 
of leptomeningeal involvement. Neuroimaging 
abnormalities can be observed in 79% of patients 
with positive cytological studies [15]. 
The treatment of carcinomatous meningitis in-
cludes intrathecal chemotherapy, radiation therapy 
or systemic chemotherapy. Treatment is palliative 
rather than curative even though prolonged re-
sponses may be seen in more chemosensitive pri-
mary neoplasms such as lymphoma, breast cancer 
and small cell lung cancer. Intrathecal chemother-
apeutic agents include methotrexate, thiotepa, 
cytarabine, or the recently available liposomal 
cytarabine (16]. These agents may be used either 
alone or in combination, but there is no evidence to 
support the superiority of combination over single 
agent therapy, and patients treated with combina-
tion drug therapy have markedly increased toxicity 
(17). Intrathecal methotrexate and thiotepa, if used 
alone, will both convert the CSF cytology to neg-
ative in one-third of previously untreated patients. 
However, 75% of those patients will develop neu-
rological progression within 8 weeks of initiating 
therapy [18]. High-dose intravenous methotrexate 
may deliver a cytotoxic CSF methotrexate con-
centration and minimize the neurologic side effects 
associated with intrathecal injection [19], but with 
greater systemic side effects. The average survival 
following diagnosis of carcinomatous meningitis is 
4-6 months [20], which can be prolonged to a mean 
of 9 months by aggressive treatment [21], with 
isolated cases of survival up to 29 months [8). 
Radiation therapy is often given palliatively to 
bulky tumor mass for symptomatic relief. 
Overall survival for patients with gallbladder 
adenocarcinoma is 25% at 5 years with median 
survival of 9.7 months [22). Early (stage I and II) 
lesions have a good prognosis and do not require 
further treatment after surgery. Survival with ad-
vanced disease is measured in weeks to months. 
In summary, patients with symptoms of cranial 
neuropathy, increased intracranial pressure, or 
spinal cord dysfunction should have carcinoma-
tous meningitis on the list of differential diagnoses, 
especially if the patient has systemic cancer. As in 
our case, neurologic symptoms of carcinomatous 
meningitis may be the presenting feature of a rare 
neoplasm. Although the prognosis of patients with 
carcinomatous meningitis is very poor, prompt 
diagnosis and treatment could possibly prolong 
survival and improve quality of life. 
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